Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, IL 60064, USA.
J Gen Physiol. 2011 Sep;138(3):341-52. doi: 10.1085/jgp.201110618. Epub 2011 Aug 15.
Transient receptor potential vanilloid 1 (TRPV1) is a ligand-gated nonselective cation channel expressed predominantly in peripheral nociceptors. By detecting and integrating diverse noxious thermal and chemical stimuli, and as a result of its sensitization by inflammatory mediators, the TRPV1 receptor plays a key role in inflammation-induced pain. Activation of TRPV1 leads to a cascade of pro-nociceptive mechanisms, many of which still remain to be identified. Here, we report a novel effect of TRPV1 on the activity of the potassium channel KCNQ2/3, a negative regulator of neuronal excitability. Using ion influx assays, we revealed that TRPV1 activation can abolish KCNQ2/3 activity, but not vice versa, in human embryonic kidney (HEK)293 cells. Electrophysiological studies showed that coexpression of TRPV1 caused a 7.5-mV depolarizing shift in the voltage dependence of KCNQ2/3 activation compared with control expressing KCNQ2/3 alone. Furthermore, activation of TRPV1 by capsaicin led to a 54% reduction of KCNQ2/3-mediated current amplitude and attenuation of KCNQ2/3 activation. The inhibitory effect of TRPV1 appears to depend on Ca(2+) influx through the activated channel followed by Ca(2+)-sensitive depletion of phosphatidylinositol 4,5-bisphosphate and activation of protein phosphatase calcineurin. We also identified physical interactions between TRPV1 and KCNQ2/3 coexpressed in HEK293 cells and in rat dorsal root ganglia neurons. Mutation studies established that this interaction is mediated predominantly by the membrane-spanning regions of the respective proteins and correlates with the shift of KCNQ2/3 activation. Collectively, these data reveal that TRPV1 activation may deprive neurons from inhibitory control mediated by KCNQ2/3. Such neurons may thus have a lower threshold for activation, which may indirectly facilitate TRPV1 in integrating multiple noxious signals and/or in the establishment or maintenance of chronic pain.
瞬时受体电位香草酸 1 型(TRPV1)是一种配体门控非选择性阳离子通道,主要表达在外周伤害感受器中。通过检测和整合各种有害的热和化学刺激,以及由于炎症介质的敏化作用,TRPV1 受体在炎症引起的疼痛中起着关键作用。TRPV1 的激活导致一系列致伤害性机制,其中许多机制仍有待确定。在这里,我们报告了 TRPV1 对钾通道 KCNQ2/3 活性的一种新的影响,KCNQ2/3 是神经元兴奋性的负调节剂。通过离子内流测定,我们揭示 TRPV1 的激活可以消除 KCNQ2/3 的活性,但反之则不行,在人胚肾(HEK)293 细胞中。电生理研究表明,与单独表达 KCNQ2/3 的对照相比,共表达 TRPV1 会导致 KCNQ2/3 激活的电压依赖性发生 7.5mV 的去极化偏移。此外,辣椒素激活 TRPV1 会导致 KCNQ2/3 介导的电流幅度减少 54%,并减弱 KCNQ2/3 的激活。TRPV1 的抑制作用似乎依赖于通过激活通道的 Ca2+内流,随后是 Ca2+敏感的磷脂酰肌醇 4,5-二磷酸耗竭和蛋白磷酸酶钙调神经磷酸酶的激活。我们还鉴定了共表达在 HEK293 细胞和大鼠背根神经节神经元中的 TRPV1 和 KCNQ2/3 之间的物理相互作用。突变研究表明,这种相互作用主要由各自蛋白质的跨膜区域介导,并与 KCNQ2/3 激活的偏移相关。总的来说,这些数据表明 TRPV1 的激活可能使神经元失去由 KCNQ2/3 介导的抑制控制。因此,这些神经元的激活阈值可能较低,这可能间接促进 TRPV1 整合多种有害信号,或在慢性疼痛的建立或维持中发挥作用。